Evaluation Of Serum Il-8 Levels as A Diagnostic Biomarker for Neisseria Gonorrhoeae Infection
Keywords:
Interleukin-8, Gonorrhea, Sensitivity, Specificity, AUCAbstract
Background: Gonorrhea is a sexually transmitted infection caused by Neisseria gonorrhoeae, often presenting at urogenital and extragenital sites. Interleukin-8 (IL-8) is a key chemokine involved in neutrophil recruitment and inflammatory response. Evaluating serum IL-8 levels may provide insight into infection severity and offer diagnostic utility. Methods: This case–control study enrolled 52 patients aged 20–50 years diagnosed with gonorrhea at Hussein Teaching Hospital in Karbala City, Iraq, from April 2024 to March 2025. Patients were categorized by infection site: urogenital, anorectal, and pharyngeal. Forty healthy individuals served as controls. Serum IL-8 concentrations were measured by ELISA. Results: Mean serum IL-8 levels were significantly elevated in patients (92.6 ± 18.4 pg/ml) compared to controls (34.7 ± 10.2 pg/ml; p < 0.001). IL-8 concentrations differed by infection site: urogenital (96.8 ± 17.5 pg/ml), anorectal (84.3 ± 15.2 pg/ml), and pharyngeal (71.6 ± 13.8 pg/ml) (F = 8.47, p < 0.001). ROC analysis revealed excellent diagnostic accuracy (AUC = 0.91), with a cut-off of 60.5 pg/ml yielding 88.5% sensitivity and 85.4% specificity. Conclusions: Serum IL-8 is markedly elevated in gonorrhea patients and varies by infection site. It demonstrates high diagnostic accuracy, supporting its potential role as a non-invasive biomarker for identifying and stratifying gonococcal infection.
References
Baggiolini, M., Walz, A., & Kunkel, S. L. (1989). Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. Journal of Clinical Investigation, 84(4), 1045–1049.
Barbee, L. A. (2013). Pharyngeal gonorrhea: a silent reservoir for transmission and resistance. Clinical Infectious Diseases, 57(Suppl 6), S203–S207.
Bos, M. P. (1992). Neutrophil response in gonococcal infection. Sexually Transmitted Diseases, 19(1), 25–29.
Cornelisse, V. J., Chow, E. P. F., Tomnay, J., Read, T. R. H., Watson, L. F., Bradshaw, C. S., & Fairley, C. K. (2017). Extragenital gonorrhea and chlamydia among men who have sex with men in Melbourne, Australia. Sexual Health, 14(3), 231–237.
De Paepe, P., De Paepe, M. E., Van den Eynde, G., & Van Deun, J. (2015). Interleukin-8 as a Diagnostic Marker of Infectious Disease. Clinical Chemistry and Laboratory Medicine, 53(5), 665–678.
Dinarello, C. A. (2018). Overview of the IL-1 family in innate inflammation and acquired immunity. Immunological Reviews, 281(1), 8–27.
Edwards, J. L. (2018). Host immune responses to Neisseria gonorrhoeae. Current Opinion in Infectious Diseases, 31(2), 72–77.
Edwards, J. L., & Apicella, M. A. (2004). The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clinical Microbiology Reviews, 17(4), 965–981.
Harada, A., Mukaida, N., & Matsushima, K. (1994). Interleukin-8 as a novel target for intervention therapy in acute inflammatory diseases. Molecular Medicine Today, 4(2), 66–70.
Jacques, J., Haustant, M., & Courcol, R. J. (2020). Inflammatory cytokine profiles in Chlamydia trachomatis infection: potential uses in diagnostics. Microbes and Infection, 22(9), 432–438.
Kovachev, S., Simeonova, D., Ivanova, I., & Mitov, I. (1999). Elevated interleukin-8 in cervical secretions during Neisseria gonorrhoeae infection. European Journal of Obstetrics & Gynecology and Reproductive Biology, 87(1), 105–108.
Kuby, J., Owen, J., Roberts, J., Sis, S., & Stranford, S. (2019). Immunology (8th ed.). W. H. Freeman.
Lewis, D. A. (2013). The role of core groups in the emergence and dissemination of antimicrobial-resistant N. gonorrhoeae. Sexually Transmitted Infections, 89(Suppl 4), iv47–iv51.
Medzhitov, R. (2008). Origin and physiological roles of inflammation. Nature, 454(7203), 428–435.
Morrow, D. A., & de Lemos, J. A. (2018). Benchmarks for the use of biomarkers in acute coronary syndromes. Nature Reviews Cardiology, 15(10), 623–638.
Newman, L., Rowley, J., Vander Hoorn, S., Wijesooriya, N. S., Unemo, M., Low, N., Stevens, G., Gottlieb, S., Kiarie, J., Temmerman, M., & Global SSA Populations Network. (2015). Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One, 10(12), e0143304.
Ramsey, K. H., Schneider, H., Cross, A. S., & Apicella, M. A. (1995). Inflammatory cytokines produced in response to experimental human gonorrhea. The Journal of Infectious Diseases, 171(5), 1478–1482. Unemo, M., Bradshaw, C. S., Hocking, J. S., De Vries, H. J. C., Francis, S. C., Mabey, D., ... Peeling, R. W. (2019). Sexually transmitted infections: challenges ahead. The Lancet Infectious Diseases, 19(6), e260–e279.
Sabharwal, B., McCarron, S. O., Stoicov, C., & Fox, J. G. (2008). IL-8 as a biomarker in pediatric urinary tract infection. Pediatric Infectious Disease Journal, 27(6), 500–503.
Slevogt, H., Kandler, U., Gatermann, S., Willam, C., Nebel, S., & Schneider, P. (2006). Role of chemokines for recruitment of neutrophilic granulocytes in interstitial pneumonia. Respiratory Research, 7(1), 56.
Tschoeke, S. K., Wodzig, W. K., Meisner, M., & Oberbeck, R. (2003). Interleukin-8 plasma levels and outcome in patients with severe sepsis. Shock, 19(5), 410–415.
Unemo, M., & Shafer, W. M. (2014). Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future. Annals of the New York Academy of Sciences, 1323(1), 97–109.
Unemo, M., Dillon, J., Esterbrook, C., & Hook, E. (2019). Challenges and future directions for antimicrobial resistance detection and treatment of Neisseria gonorrhoeae. Clinical Microbiology Reviews, 32(3), e00072-18.
Wi, T., Lahra, M. M., Ndowa, F., Bala, M., Dillon, J.-A. R., Ramon-Pardo, P., ... Unemo, M. (2017). Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action. PLOS Medicine, 14(7), e1002344.
Workowski, K. A., & Bolan, G. A. (2015). Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and Reports, 64(RR-03), 1–137.
World Health Organization. (2022). Global health estimates: Leading causes of death and disability. WHO Publishing
